Serum Levels of Tumor Necrosis Factor and Interleukin-13 Are Elevated in Patients with Localized Scleroderma

Publisher： Karger

E-ISSN： 1421-9832|207|2|141-147

ISSN： 1018-8665

Source： Dermatology, Vol.207, Iss.2, 2003-08, pp. : 141-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Serum Levels of Tumor Necrosis Factor Alpha in Lichen planus

By  

Dermatology, Vol. 207, Iss. 4, 2004-01 ,pp. : 367-370

Karger

Access to resources Recommend Favorite

Elevated Serum KL-6 Levels in Patients with Systemic Sclerosis: Association with the Severity of Pulmonary Fibrosis

By  

Dermatology, Vol. 200, Iss. 3, 2000-05 ,pp. : 196-201

Karger

Access to resources Recommend Favorite

A Clue for Telangiectasis in Systemic Sclerosis: Elevated Serum Soluble Endoglin Levels in Patients with the Limited Cutaneous Form of the Disease

By  

Dermatology, Vol. 213, Iss. 2, 2006-08 ,pp. : 88-92

Karger

Access to resources Recommend Favorite

Lack of Association between the Promoter Polymorphisms at Positions –308 and –238 of the Tumor Necrosis Factor Alpha Gene and Psoriasis vulgaris in Japanese Patients

By  

Dermatology, Vol. 207, Iss. 4, 2004-01 ,pp. : 371-374

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite